Parnassus Investments
Parnassus Endeavor Fund
Parnassus Endeavor Fund Novo Nordisk A/S stake
total: 118
Parnassus Endeavor Fund NVO trades
- Total transactions:
- 6
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Reduced:
- 2
- Held since:
- 2024 Q4
- Held for:
- 5 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q2 report, Parnassus Endeavor Fund doesn't hold any Novo Nordisk A/S (NVO) shares. To date, the estimated cost basis is nearly $79.14 for "buy" trades and estimated average "sell" price is $50.89. Parnassus Endeavor Fund first purchased NVO in 2024 Q4, initially acquiring 593,722 shares. Since the initial investment in Novo Nordisk A/S (NVO), Parnassus Endeavor Fund has made 5 more transactions.
When did Parnassus Endeavor Fund sell Novo Nordisk A/S (NVO)?
Parnassus Endeavor Fund sold off the entire Novo Nordisk A/S (NVO) position in 2026 Q1.
When did Parnassus Endeavor Fund buy Novo Nordisk A/S (NVO)?
Parnassus Endeavor Fund first invested in Novo Nordisk A/S (NVO) in 2024 Q4 at the reported quarter-end price of $86.02 per share.
What's the cost basis of Parnassus Endeavor Fund's NVO stake?
The estimated cost basis for Novo Nordisk A/S (NVO) stake is around $79.14 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $79.14
- Weighted AVG sell price:
- $50.89
Parnassus Endeavor Fund's historical trades in Novo Nordisk A/S
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.00%
|
0
|
$50.88
|
|
-100% (-964,103)
|
-1.03%
|
|
2025 Q4
|
1.03%
|
964,103
|
$50.88
|
$49,053,561
|
-4.46% (-45,017)
|
-0.05%
|
|
2025 Q3
|
1.19%
|
1,009,120
|
$55.49
|
$55,996,069
|
-0.24% (-2,426)
|
-0%
|
|
2025 Q2
|
1.54%
|
1,011,546
|
$69.02
|
$69,816,905
|
+9.23% (+85,463)
|
+0.13%
|
|
2025 Q1
|
1.44%
|
926,083
|
$69.44
|
$64,307,204
|
+55.98% (+332,361)
|
+0.52%
|
|
2024 Q4
|
1.06%
|
593,722
|
$86.02
|
$51,071,966
|
new
|
+1.06%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.